Outcomes in Kawasaki disease patients with coronary artery abnormalities at admission

Ryusuke Ae1, Joseph Y Abrams2, Ryan A Maddox2

  • 1Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA; Division of Public Health, Center for Community Medicine, Jichi Medical University, Tochigi, Japan.

Insights

Kawasaki disease (KD) coronary artery lesions (CALs) often improve, but larger CALs, older age, recurrent KD, family history, and delayed treatment are linked to worse outcomes. Prompt diagnosis and intervention are crucial for better coronary health in KD patients.

Area of Science:

  • Pediatrics
  • Cardiology
  • Immunology

Background:

  • Kawasaki disease (KD) can cause coronary artery lesions (CALs).
  • While CALs can improve, sub-acute outcomes at admission are less understood.
  • This study focuses on CALs detected upon initial diagnosis of KD.

Purpose of the Study:

  • To investigate the sub-acute outcomes of coronary artery lesions (CALs) in patients diagnosed with Kawasaki disease (KD).
  • To identify factors associated with the improvement, stability, or progression of CALs within 30 days of onset.
  • To inform clinical management strategies for Kawasaki disease.

Main Methods:

  • Analysis of a nationwide Japanese KD survey dataset.
  • Inclusion of patients with CALs detected at admission, treated with IVIG within 10 days of onset.
  • Categorization of coronary outcomes (improved, unchanged, progressed) and use of ordinal logistic regression to identify associated factors.

Main Results:

  • Out of 2024 patients, 76.5% showed improved CALs, 19.3% unchanged, and 4.2% progressed.
  • Factors associated with worse outcomes included larger CALs (aneurysms, giant aneurysms), age ≥60 months, recurrent KD, parental history of KD, and delayed admission (8-10 days).
  • Over 80% of patients with coronary artery dilatations experienced improvement.

Conclusions:

  • Patients with larger CALs, older age, recurrent KD, or family history may need intensive treatment.
  • Delayed admission correlates with poorer coronary outcomes, emphasizing the need for prompt KD diagnosis and treatment.
  • Early intervention is key to improving coronary outcomes in Kawasaki disease.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
140
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
154
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
285
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
170
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
556
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
192